United Kingdom

Middle East a priority market for UK medtech companies

Insights

18-Jan-18 Most UK medtech companies anticipate exports to the Middle East to increase over the next five years says a new business survey by the UK’s medtech association, finding 51% of members anticipate improved turnover in the region. [image: Med-tech News]

GGM's CEO Pete Read invited to speak on international panel at Private Acute Healthcare conference in London

Events

GGM's CEO Pete Read was invited to speak about "London and the international market", at the Private Acute Healthcare Conference on 12-Oct-17. Pete said that while UK healthcare is generally well-regarded in China, the UK could do more to promote specific services and institutions. [Image: IMTJ]

Foreign healthcare companies should be selective about opportunities in China, says Global Growth Markets

Events

Speaking at the China Britain Business Council SME Forum in Bristol, UK, GGM said foreign companies looking for opportunities in China's healthcare market should be selective, pointing out the increasingly competitive situation in first tier cities and Level III hospitals. [Image: SCMP]

Shanghai's MicroPort to pay USD190 mn for LivaNova's cardiac business

Insights

26-Nov-17 Shanghai medical device maker MicroPort Scientific will pay USD190 mn to acquire the cardiac rhythm management business of the UK's LivaNova, expanding the two companies' ongoing partnership to bring a range of cardiac rhythm devices to China. [image: LivaNova; MicroPort]

UK-Shanghai collaborations: pioneering businesses win funding

28-Oct-17 Innovate UK and Shanghai's Science & Technology Department announced they will fund UK and Shanghai companies to work together on innovation, including in healthcare. For example Oxford-based Genefirst and Fosun Med-Tech are developing a non-invasive test for cancer gene mutations. [image: GOV.UK]

Middle East a priority market for UK medtech companies

GGM's CEO Pete Read invited to speak on international panel at Private Acute Healthcare conference in London

Foreign healthcare companies should be selective about opportunities in China, says Global Growth Markets

Shanghai's MicroPort to pay USD190 mn for LivaNova's cardiac business

UK-Shanghai collaborations: pioneering businesses win funding

Share

Latest

About us

Why Global Growth Markets?

Contact